PERIPHERAL VEIN THROMBUS EXTENSION

PERIPHERAL VEIN THROMBUS EXTENSION was reported 39 times

PERIPHERAL VEIN THROMBUS EXTENSION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Thrombopoietin Receptor Agonist [EPC] 2 0.0001
1 Human Immunoglobulin G [EPC] 2 0.0001
2 Asparagine-specific Enzyme [EPC] 1 0.0001
3 Provitamin D2 Compound [EPC] 1 0.0000
4 Progestin [EPC] 3 0.0000
5 Nucleoside Metabolic Inhibitor [EPC] 2 0.0000
6 Janus Kinase Inhibitor [EPC] 1 0.0000
7 Platinum-based Drug [EPC] 1 0.0000
8 Proton Pump Inhibitor [EPC] 2 0.0000
9 Osmotic Laxative [EPC] 1 0.0000
10 Vitamin D [EPC] 1 0.0000
11 Corticosteroid [EPC] 4 0.0000
12 Vitamin B12 [EPC] 1 0.0000
13 Vitamin C [EPC] 1 0.0000
14 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
15 GLP-1 Receptor Agonist [EPC] 1 0.0000
16 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000